Pretreatment Neutrophil/Lymphocytes Ratio in Non-Metastatic Colon Cancer as a Prognostic and Predictive Factor: A Retrospective Study — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Pretreatment Neutrophil/Lymphocytes Ratio in Non-Metastatic Colon Cancer as a Prognostic and Predictive Factor: A Retrospective Study
Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Suez Canal University, Ismaïlia, Egypt
,
Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Suez Canal University, Ismaïlia, Egypt
,
Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Suez Canal University, Ismaïlia, Egypt
,
Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Suez Canal University, Ismaïlia, Egypt
1 Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Suez Canal University, Ismaïlia, Egypt
2 Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Suez Canal University, Ismaïlia, Egypt
3 Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Suez Canal University, Ismaïlia, Egypt
4 Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Suez Canal University, Ismaïlia, Egypt
Background: In developed countries, colon cancer is the second most preva lent cancer, only exceeded by prostate cancer in men and breast cancer in women. After Hepatocellular carcinoma, breast cancer, bladder cancer, lung cancer, Non-Hodgkin Lymphoma and brain tumors, colon cancer is the 7 th most common cancer in Egypt, in both sexes, representing 3.47% and 3%, in both male and female cancers, respectively. Aim of the Work: The aim of this study was to evaluate the prognostic and predictive significance of pretreatment Neutrophil/lymphocytes ratio (NLR), in terms of disease-free survival (DFS) and recurrence, in high-risk stage II and stage III Colorectal cancer patients who underwent curative resection. Patients and Methods: We retrospectively evaluated 103 patients, who were submitted to upfront surgery as first therapeutic option in curative intent, between January 2017 and December 2018. Pretreatment Neutrophil/<br/>lymphocytes ratio (NLR), as well as demographics, clinical, histopathologic, and laboratory data were analyzed. Univariate and multivariate analyses were conducted to identify prognostic factors associated with disease free survival (DFS) and recurrence. Results: The cutoff point of Neutrophils/lymphocytes ratio (NLR) was calculated with Kaplan-Meier curves and log-rank test to 3. This study revealed that neutrophils/lymphocytes ratio (NLR) was significantly associated with disease free survival (p < 0.001*). Also, there w as no difference in efficacy between both chemotherapy regimens FOLFOX and XELOX in both high-risk stage II and stage III colon cancer regarding disease free survival & the toxicity profile associated with each regimen and its grades between patients. Conclusion: Our study suggests that preoperative Neutrophils/lymphocytes ratio (NLR) more than 3 may be an independent prognostic marker for TTR (time to recur rence) in high-risk stage II and stage III colon cancer patients.
KeywordsPretreatment Neutrophil/Lymphocytes Ratio-Non-Metastatic Cancer Colon
Ibrahim, A.S., Khaled, H.M., Mikhail, N.N., Baraka, H. and Kamel, H. (2014) Cancer Incidence in Egypt: Results of the National Population-Based Cancer Registry Program. Journal of Cancer Epidemiology, 2014, Article ID: 437971. https://doi.org/10.1155/2014/437971
Forman, D., et al. (2014) Colorectal Cancer. In: Stewart, B.W. and Wild, C.P., Eds., World Cancer Report, The International Agency for Research on Cancer, World Health Organization, IARC Press, Lyon.
Altman, J. (2019) Colorectal Cancer: Diagnosis. ASCO, Alexandria.
Balkwill, F. and Mantovani, A. (2010) Cancer and Inflammation: Implications for Pharmacology and Therapeutics. Clinical Pharmacology & Therapeutics, 87, 401-406. https://doi.org/10.1038/clpt.2009.312
Roxburgh, C.S. and McMillan, D.C. (2010) Role of Systemic Inflammatory Response in Predicting Survival in Patients with Primary Operable Cancer. Future Oncology, 6, 149-163. https://doi.org/10.2217/fon.09.136
McMillan, D.C. (2009) Systemic Inflammation, Nutritional Status and Survival in Patients with Cancer. Current Opinion in Clinical Nutrition & Metabolic Care, 12, 223-226. https://doi.org/10.1097/MCO.0b013e32832a7902
Diakos, C.I., et al. (2016) Is Baseline Neutrophil to Lymphocyte Ratio (NLR) an Independent Prognostic Biomarker for Progression Free Survival (PFS) and Overall Survival (OS) in Metastatic Colorectal Cancer (mCRC)? Analysis of the AGITG MAX Study. Annals of Oncology, 27, Article No. vi197. https://doi.org/10.1093/annonc/mdw370.137
Petrie, H.T., Klassen, L.W. and Kay, H.D. (1985) Inhibition of Human Cytotoxic T Lymphocyte Activity in Vitro by Autologous Peripheral Blood Granulocytes. The Journal of Immunology, 134, 230-234. https://doi.org/10.4049/jimmunol.134.1.230
Oken, M.M., et al. (1982) Toxicity and Response Criteria Of The Eastern Cooperative Oncology Group. American Journal of Clinical Oncology, 5, 649-655. https://doi.org/10.1097/00000421-198212000-00014
Malietzis, G., et al. (2014) A Preoperative Neutrophil to Lymphocyte Ratio of 3 Predicts Disease-Free Survival after Curative Elective Colorectal Cancer Surgery. Annals of Surgery, 260, 287-292. https://doi.org/10.1097/SLA.0000000000000216
Chiang, S.-F., et al. (2012) Can Neutrophil-to-Lymphocyte Ratio Predict the Survival of Colorectal Cancer Patients Who Have Received Curative Surgery Electively? International Journal of Colorectal Disease, 27, 1347-1357. https://doi.org/10.1007/s00384-012-1459-x
Ozdemir, Y., Akin, M.L., Sucullu, I., Balta, A.Z. and Yucel, E. (2014) Pretreatment Neutrophil/Lymphocyte Ratio as a Prognostic Aid in Colorectal Cancer. Asian Pacific Journal of Cancer Prevention, 15, 2647-2650. https://doi.org/10.7314/APJCP.2014.15.6.2647
Shin, J.S., Suh, K.W. and Oh, S.Y. (2015) Preoperative Neutrophil to Lymphocyte Ratio Predicts Survival in Patients with T1-2N0 Colorectal Cancer. Journal of Surgical Oncology, 112, 654-657. https://doi.org/10.1002/jso.24061
Jankova, L., Dent, O.F., Chan, C., Chapuis, P. and Clarke, S.J. (2013) Preoperative Neutrophil/Lymphocyte Ratio Predicts Overall Survival but Does Not Predict Recurrence or Cancer-Specific Survival after Curative Resection of Node-Positive Colorectal. BMC Cancer, 13, Article No. 442. https://doi.org/10.1186/1471-2407-13-442
Charan, J. and Biswas, J. (2013) How to Calculate Sample Size for Different Study Designs in Medical Research? Indian Journal of Psychological Medicine, 35, 121-126. https://doi.org/10.4103/0253-7176.116232
Dell’Aquila, E., et al. (2018) Prognostic and Predictive role of Neutrophil/Lymphocytes Ratio in Metastatic Colorectal Cancer: A Retrospective Analysis of the TRIBE Study by GONO. Annals of Oncology, 29, 924-930. https://doi.org/10.1093/annonc/mdy004
Yamamoto, T., Kawada, K. and Obama, K. (2021) Inflammation-Related Biomarkers for the Prediction of Prognosis in Colorectal Cancer Patients. International Journal of Molecular Sciences, 22, Article No. 8002. https://doi.org/10.3390/ijms22158002
Sunakawa, Y., et al. (2018) Immune-Related Genes to Dominate Neutrophil-Lymphocyte Ratio (NLR) Associated with Survival of Cetuximab Treatment in Metastatic Colorectal Cancer. Clinical Colorectal Cancer, 17, e741-e749. https://doi.org/10.1016/j.clcc.2018.08.002
Bhattacharjee, D. and Quirke, P. (2021) What Is the Role of the Neutrophil: Lymphocyte Ratio in Colorectal Cancer? Turkish Journal of Colorectal Disease, 31, 1-12. https://doi.org/10.4274/tjcd.galenos.2020.2020-9-3
Absenger, G., et al. (2013) Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Clinical Outcome in Patients with Stage II and III Colon Cancer. Anticancer Research, 33, 4591-4594.
Liu, H., et al. (2010) The Baseline Ratio of Neutrophils to Lymphocytes Is Associated with Patient Prognosis in Rectal Carcinoma. Journal of Gastrointestinal Cancer, 41, 116-120. https://doi.org/10.1007/s12029-009-9125-4
Carruthers, R., et al. (2012) Systemic Inflammatory Response Is a Predictor of Outcome in Patients Undergoing Preoperative Chemoradiation for Locally Advanced Rectal Cancer. Colorectal Disease, 14, e701-e707. https://doi.org/10.1111/j.1463-1318.2012.03147.x
Kim, I.Y., You, S.H. and Kim, Y.W. (2014) Neutrophil-Lymphocyte Ratio Predicts Pathologic Tumor Response and Survival after Preoperative Chemoradiation for Rectal Cancer. BMC Surgery, 14, Article No. 94. https://doi.org/10.1186/1471-2482-14-94
Shen, J., et al. (2017) Prognostic Role of Neutrophilto Lymphocyte Ratio in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy. Medical Science Monitor, 23, 315-324. https://doi.org/10.12659/MSM.902752
Nagasaki, T., et al. (2015) Prognostic Impact of Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Low Rectal Cancer Treated with Preoperative Chemoradiotherapy. Digestive Surgery, 32, 496-503. https://doi.org/10.1159/000441396
Vallard, A., et al. (2018) Outcomes Prediction in Pre-Operative Radiotherapy Locally Advanced Rectal Cancer: Leucocyte Assessment as Immune Biomarker. Oncotarget, 9, 22368-22382. https://doi.org/10.18632/oncotarget.25023
Ward, W.H., et al. (2018) Predictive Value of Leukocyte- and Platelet-Derived Ratios in Rectal Adenocarcinoma. Journal of Surgical Research, 232, 275-282. https://doi.org/10.1016/j.jss.2018.06.060
Ke, T.-M., et al. (2020) High Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Predict Poor Survival in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy. Medicine, 99, e19877. https://doi.org/10.1097/MD.0000000000019877